biologics exclusivity

Intellectual property protection in biotechnology sits at the intersection of scientific innovation, regulatory oversight, and commercial strategy. In the United States, where biotech innovation is heavily driven by venture funding and institutional research, robust IP frameworks are essential for securing market exclusivity and enabling long-term return on investment. From gene therapies to biologics, the ability … Read more